entertainment -WSS

entertainment

author：knowledge 2025-09-30 11:58:38 - browse：3587

What happens when an approved drug doesn’t work? Why don’t patients want gene therapy? And is MASH still a big deal?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Bioethicist Holly Fernandez Lynch joins us to discuss the case of Amylyx Pharmaceuticals’ treatment for ALS and what its failure means for drug development. We also discuss the latest news in the life sciences, including a tepid reception for gene therapies, the future of CAR-T cancer treatment, and the first approved medicine for a prevalent liver disease.

For more on what we cover, here’s more on Amylyx; here’s the story on hemophilia gene therapy; here’s the news on Madrigal Pharmaceuticals’ drug for MASH; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Affordable Connectivity Program vital to health care, experts say

entertainment

focus

WSS

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Obesity drug from Roche shows promise in early study

Hottest summer in 2,000 years puts focus on extreme heat, health

Lilly’s weekly insulin works as well as daily products, new studies show

Driven by the pandemic, applicants flood public health schools

STAT series 'Denied by AI' wins major journalism prizes

leisure time

entertainment

Wikipedia

What does generative AI mean for health care? We asked experts

STAT reporters are Pulitzer Prize finalists for investigative reporting

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Study identifies new proteins linked to dementia risk 25 years later

State Dept. review finds Biden bears some blame for Afghanistan failures

Supreme Court to hear if Covid misinformation is protected speech

Walensky prepares to leave CDC — and Congress — behind

Galapagos to make CAR

Medicare details structure of new drug price negotiation program

Driven by the pandemic, applicants flood public health schools

knowledge

Stanford president faces new allegations over 1999 paper

HHS suspends federal funding for EcoHealth Alliance

Obesity drug from Roche shows promise in early study

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Cherokee Nation medical school graduates its first class

CVS is willing to dump 10% of its Medicare Advantage members

explore

entertainment

focus

entertainment